000 01461 a2200361 4500
005 20250517170840.0
264 0 _c20180718
008 201807s 0 0 eng d
022 _a1473-5857
024 7 _a10.1097/YIC.0000000000000195
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEmsley, Robin
245 0 0 _aReal-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.
_h[electronic resource]
260 _bInternational clinical psychopharmacology
_c01 2018
300 _a15-33 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHyperprolactinemia
_xblood
650 0 4 _aPaliperidone Palmitate
_xadverse effects
650 0 4 _aPragmatic Clinical Trials as Topic
_xmethods
650 0 4 _aPsychotic Disorders
_xblood
650 0 4 _aRandomized Controlled Trials as Topic
_xmethods
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aStatistics as Topic
_xmethods
700 1 _aParellada, Eduard
700 1 _aBioque, Miquel
700 1 _aHerrera, Berta
700 1 _aHernando, Teresa
700 1 _aGarcĂ­a-Dorado, Marta
773 0 _tInternational clinical psychopharmacology
_gvol. 33
_gno. 1
_gp. 15-33
856 4 0 _uhttps://doi.org/10.1097/YIC.0000000000000195
_zAvailable from publisher's website
999 _c27474622
_d27474622